3d
MedPage Today on MSNTrial Data Shed Light on ALS Clinical ResearchThe phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...
A proposed block in β-alanine-α-ketoglutarate transaminase would expand the free β-alanine pool, thus increasing tissue carnosine. β-alanine is a Central-nervous-system depressant. Associated ...
While this is considered clinically significant, it is unknown how often ceftriaxone induces such substantial increases in hepatic transaminase levels. Our patient had severe meningitis ...
The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic methods for metabolic dysfunction–associated steatohepatitis (MASH).
14d
Asian News International on MSNShilpa Medicare Limited: Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASHShilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results